Britannia Life Sciences Invests $5M in Asset-Backed Loans to Boost Cash Flow and Shareholder Value
Britannia Life Sciences Inc. has invested $5 million in an asset-backed loan portfolio, leveraging treasury capital from the sale of a former UK subsidiary to generate immediate cash flow for shareholders.
2 minutes to read